-
Identifying Neural Adaptations Underlying Cocaine Addiction
Northwestern Medicine scientists and co-authors defined a role for the WAVE1 protein in the cellular mechanisms behind cocaine addiction.
-
Celebrating Sex Inclusion in Biomedical Research
Northwestern Medicine hosted a symposium for the one-year anniversary of the implementation of the National Institutes of Health’s landmark sex-inclusion policy.
-
Updating Red Blood Cell Transfusion Guidelines
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
-
Housestaff Panel Helps Medical Students Prepare for Residency
A new resident-led program at Northwestern fosters community among underrepresented minority students in undergraduate and graduate medical education programs.
-
Pioneering Astronaut and Physician Keynotes Martin Luther King, Jr. Commemoration
Mae Jemison, MD, a physician and the first woman of color to travel into space, delivered the keynote address during this year’s commemoration of Martin Luther King, Jr.
-
Lurie Cancer Center to Lead Trial for Rare Cancer Patients
A novel national trial for people with no established alternative to treat their rare cancers is being co-led by Northwestern Medicine investigators, who helped conceive of and develop the project.
-
Jet Lag Impairs Performance of Major League Baseball Players
When Major League Baseball players travel in a way that misaligns their internal 24-hour clock with the natural environment and its cycle of sunlight, they suffer negative consequences, according to a recent study.
-
Feinberg Rises in NIH Rankings
Northwestern University Feinberg School of Medicine rose to 16th place among U.S. medical schools in National Institutes of Health funding in 2016, rising two spots in the rankings reported by the Blue Ridge Institute for Medical Research.
-
Student Uncovers a Potential Path to Treating Age-Related Memory Loss
A Northwestern Medicine study, led by a PhD student, found that overexpressing a protein called CREB improved memory impairments in aged rats.
-
Mission to Keep Seniors at Home Keeps Alumna Home at Northwestern
A passion for senior care brought Lee Lindquist, ’00 MD, ’03 ’05 GME, ’05 MPH, ’10 MBA, to Northwestern as a first-year medical student in 1996 and has kept her here for two decades.
-
Clinical Trials Evaluate New Treatment for Anal Cancer
The addition of the drug cetuximab to standard chemoradiation reduced the incidence of relapse for patients with anal cancer, but was associated with significant adverse effects, according to recent Northwestern Medicine clinical trials.
-
Scientists Identify Structural Changes in Herpesvirus Fusion
Northwestern and Stanford scientists have uncovered new details on the structure of herpesviruses that allow them to initiate a fusion event to infect host cells.
-
Celebrating a Half-Century of Leadership in Bone Biology
Former and current colleagues, students and friends gathered to celebrated the career of Paula Stern, PhD, an authority on bone and mineral health research, and a respected leader and educator.
-
Children Born With Heart Defects at Increased Risk for Epilepsy
Children with congenital heart disease have a higher risk of epilepsy through adulthood, according to a recent Northwestern Medicine study.
-
Medical Students Start the New Year With Wellness Activities
Medical students attended sessions addressing different aspects of wellness during a week dedicated to student well-being.
-
Clinical Trial Assesses Non-Hodgkin Lymphoma Drug
A recent clinical trial assessed the efficacy and safety of the drug ibrutinib in patients with Waldenstrom’s macroglobulineaemia, a type of non-Hodgkin lymphoma, who were not responding to other treatments.
-
Medical Student Charts a Map of Memory in the Brain
Kelsey Bowman extended her medical school program from four years to five years to develop a test to map regions of the brain associated with memory.
-
Engineering Nanomaterials to Deliver Precise Treatments for Heart Disease
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
-
Antiviral Drug Prevents Recurrence of Hepatitis C in Liver Transplant Patients
Patients with hepatitis C virus infection who received an antiviral drug around the time they underwent liver transplantation saw a high rate of sustained virologic response, according to a Northwestern Medicine clinical trial.
-
Testing a New Treatment for Crohn’s Disease
A drug called ustekinumab significantly improved symptoms for patients with moderate to severe Crohn’s disease, according to Northwestern Medicine clinical trials published in the New England Journal of Medicine.
